Vitamin K2 Market Size and Forecasts (2020 – 2030)

Vitamin K2 Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (MK-4, MK-7, and Combination Drugs), Dosage Forms (Capsules & Tablets, Powder, and Oils), Source (Natural and Synthetic), Application (Pharmaceuticals, Nutraceuticals and Food, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPRE00028583 Category: Tags: , ,

$3,185$5,985

Description

The vitamin K2 market size is projected to reach US$ 1.160 billions by 2030 from US$ 0.144 billions in 2022; the market is estimated to record a CAGR of 29.7% from 2022 to 2030.

The vitamin K2 market growth is attributed to increasing prevalence of CVD and growing cases of osteoporosis in adults and newborns. However, limited awareness regarding benefits of vitamin K2 is hindering the market growth.

Increasing Prevalence of CVD Propels Vitamin K2 Market Growth

Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to the World Health Organization, CVD is a leading cause of death, registering ~17.9 million deaths every year globally. Additionally, as per the European Environment Agency, every year, more than 6 million CVD are diagnosed, and over 1.7 million people die from CVD, representing 37% of all deaths in in the European Union in 2022, making it a leading cause of death.

Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.

Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the vitamin K2 market.

Vitamin K2 Market: Segmental Overview

The vitamin K2 market is segmented on the basis of product, dosage forms, source, application, and geography.

The vitamin K2 market, by product, is segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Menaquinone-7 (MK-7) is an advanced, fat-soluble form of vitamin K2 that serves multiple bodily functions. Only vitamin K2 in the form of MK-7 has been proven to provide 24-hour protection to bones and teeth from a single daily dose. MK-7 has a much longer half-life in the body and stays in the blood the longest than other forms of vitamin K2, owing to its presence not only in liver tissues but also in bones, arteries, and soft tissues. Therefore, MK-7 supplementation must only be taken once daily. According to MenaQ7, 45 mcg of MK-7 per day can increase carboxylation and activate vitamin K-dependent proteins, such as osteocalcin for bone health and Matrix GLA Protein (MGP) for heart health.

Based on dosage forms, the vitamin K2 market is segmented into capsules & tablets, powder, and oils. In 2022, the powder segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Vitamin powder disintegrates quickly in water and other liquids. When taken with water, vitamin K2 products get absorbed faster in powder form and are more effective than in capsule or tablet form. High calcium level is controlled with vitamin K2 powder. Vitamin K2 helps reduce calcium absorption and lower the risk of developing kidney stones or osteoporosis. Blood-thinning drugs (anticoagulants), such as warfarin, can cause bleeding, which vitamin K2 stops and slows down. Thus, owing to such factors, the powder segment is expected to grow considerably during the forecast period.

Based on source, the vitamin K2 market is bifurcated into natural and synthetic. In 2022, the natural segment held a larger market share and is estimated to register a faster CAGR during 2022–2030. Natural vitamin K2 found in dark leafy greens is essential for metabolism and blood clotting. Vitamin K2, or menaquinone, is present in small amounts in offal and fermented foods. Gut bacteria also produce vitamin K2. Fermented foods are good vitamin K2 sources. Offal and high-fat dairy products contain significant amounts of vitamin K2 because of their fat-soluble properties. Bacteria residing in the human gut also produce small amounts of K2.

Based on application, the vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. In 2022, the pharmaceuticals segment held the largest market share, and the nutraceuticals and food segment is estimated to register the fastest CAGR during 2022–2030. The nutraceuticals and food segment is expected to grow rapidly due to high customer demand for nutritional and dietary supplements to address various nutritional deficiencies. Vitamin K2 is added as a dietary supplement in food to increase its nutritional value. Depending on the end-use direction, vitamin K2 can be consumed in food, health and dietary supplements, and functional foods. It is also found in a traditional Japanese dish called “natto.” Natto is composed of fermented soybeans using different types of bacteria, including propionic acid bacteria and lactic acid bacteria.

Vitamin K2 Market: Geographical Overview

Based on geography, the vitamin K2 market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the vK2 market. Asia Pacific is expected to register the highest CAGR in the global vK2 market during 2022–2030.

The Asia Pacific vitamin K2 market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the vitamin K2 market in this region is widely driven by collaborations between companies, rising prevalence of cardiovascular disease (CVD), and an increasing aging population. A research article, “Cardiovascular Disease Mortality and Potential Risk Factor in China,” published in April 2022, mentioned that cardiovascular disease (CVD) is one of the serious healthcare burdens in China. In China, 290 million people suffer from coronary heart disease (11 million), cardiac disorders (13 million), heart failure (4.5), pulmonary heart disease (5 million), rheumatic heart disease (2.5 million), congenital heart disease (2 million), and hypertension (245 million). The article also states that China accounts for 40% of the total mortality related to CVD globally. Vitamin K2 plays a vital role in cardiovascular health by regulating calcium homeostasis. Vitamin K2 supplements strongly correlate with enhanced cardiovascular outcomes by modifying arterial stiffness and systemic calcification. Supported by its affordability and Food and Drug Administration (FDA)-proven safety, vitamin K2 supplements are a viable and favorable option to enhance cardiovascular outcomes. Thus, the growing burden and prevalence of CVD among the population in China is expected to increase the demand for vitamin K2 supplements, thereby boosting the market growth.

Several market players are adopting organic strategies to stay competitive in the market. For instance, In June 2022, Balchem Corporation announced the complete acquisition of Kappa Bioscience AS. The acquisition has helped Balchem expand its product portfolio by adding Kappa Bioscience AS’s specialty vitamin K2.

• In October 2022, PLT Health Solutions, Inc. announced that non-GMO Project company offered it non-GMO verification for its menatto. In March 2022, the company introduced menatto in the US, which is manufactured by edible oils producer J-Oil Mills, Tokyo, Japan.

• In May 2023, DSM merged into Firmenich to create a robust platform for reinventing, manufacturing, and combining vital nutrients, flavors, and fragrances. The announcement was made to create a new brand called dsm-firmenich, under which the companies will have a competitive edge and growth opportunities for nutrition, health, and beauty segments.

• In April 2023, DSM announced negotiations with Adare Pharma Solutions to acquire its Adare Biome for US$ 301.2 million (€275 million). The acquisition will enable DSM to expand its human health and animal nutrition offerings.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

MK-7 Segment by Product to Account Largest Share in Vitamin K2 Market during 2022–2030.

According to our new research study on “Vitamin K2 Market Forecast to 2030 –Global Analysis – by product, dosage forms, source, and application,” the market was valued at US$ 0.144 billions in 2022; and is expected to reach US$ 1.160 billions by 2030 and it estimated to grow at a rate of 29.7% from 2022 to 2030. The report highlights trends prevailing in the market, and factors driving and hindering the vitamin K2 market growth.

The vitamin K2 market growth is due to the increasing prevalence of CVD and growing cases of osteoporosis in adults and newborns. Whereas limited awareness regarding benefits of vitamin K2 is hindering the market growth.

The vitamin K2 market, by product, is segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Menaquinone-7 (MK-7) is an advanced, fat-soluble form of vitamin K2 that serves multiple bodily functions. Only vitamin K2 in the form of MK-7 has been proven to provide 24-hour protection to bones and teeth from a single daily dose. MK-7 has a much longer half-life in the body and stays in the blood the longest than other forms of vitamin K2, owing to its presence not only in liver tissues but also in bones, arteries, and soft tissues. Therefore, MK-7 supplementation must only be taken once daily. According to MenaQ7, 45 mcg of MK-7 per day can increase carboxylation and activate vitamin K-dependent proteins, such as osteocalcin for bone health and Matrix GLA Protein (MGP) for heart health.

In terms of geography, the global vitamin K2 market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.

The market in North America is further divided into the US, Canada, and Mexico. North America holds the largest share of the vitamin K2 market. The market growth in North America is attributed to the rising adoption of nutraceutical supplements for vitamin K2. In addition, the increasing prevalence of cardiovascular diseases and orthopedic disorders, along with rising cases of vitamin K2 deficiency in children and geriatric population, is expected to fuel the vitamin K2 market.

The US accounts for the largest share of the vitamin K2 market in North America. The increasing prevalence of cardiovascular diseases and orthopedic disorders, such as osteoporosis and arthritis, has increased the demand for vitamin K2, as it helps in the better absorption of calcium and other nutrients, strengthening cardiac and bone health. According to the Centers for Disease Control and Prevention (CDC), in 2021, ~695,000 people died from heart disease in the US, coronary heart disease being the most common type of heart disease that resulted in the death of 375,476 people in the country. Moreover, various strategic developments such as product launches, acquisitions, and mergers have been taking place in the country, which are contributing to the market growth. In October 2022, Kappa Bioscience launched its first organic grade vitamin K2-MK7 in the US market under the brand name K2Vital. It is the first US Department of Agriculture (USDA) organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications in the US market. Therefore, the rising prevalence of cardiovascular diseases and orthopedic disorders, along with an increase in strategic collaboration, is expected to drive the vitamin K2 market growth in the US.

Lesaffre, DSM-Firmenich, BIOLAB FARMACÊUTICA, PLT Health Solutions, BASF SE, AdvaCare Pharma, Metabolics ltd, Yamamoto Nutrition, and Fermenta Biotech Limited are among the leading companies operating in the vital signs monitoring devices market.

Companies operating in the vitamin K2 market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and product approvals, mergers & acquisitions, collaborations, and partnerships are among the growth strategies witnessed in the vitamin K2 market.

A few of the significant developments by key market players are listed below.

Various initiatives taken by leading players operating in the vitamin K2 market are listed below:

• In June 2022, Balchem Corporation announced the complete acquisition of Kappa Bioscience AS. The acquisition has helped Balchem expand its product portfolio by adding Kappa Bioscience AS’s specialty vitamin K2.

• In October 2022, PLT Health Solutions, Inc. announced that non-GMO Project company offered it non-GMO verification for its menatto. In March 2022, the company introduced menatto in the US, which is manufactured by edible oils producer J-Oil Mills, Tokyo, Japan.

• In May 2023, DSM merged into Firmenich to create a robust platform for reinventing, manufacturing, and combining vital nutrients, flavors, and fragrances. The announcement was made to create a new brand called dsm-firmenich, under which the companies will have a competitive edge and growth opportunities for nutrition, health, and beauty segments.

• In April 2023, DSM announced negotiations with Adare Pharma Solutions to acquire its Adare Biome for US$ 301.2 million (€275 million). The acquisition will enable DSM to expand its human health and animal nutrition offerings.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Hybrid Composites Market, by Fiber Type
1.3.2 South & Central America Hybrid Composites Market, by Resin
1.3.3 South & Central America Hybrid Composites Market, by Application
1.3.4 South & Central America Hybrid Composites Market, by Country
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis formulation:
3.2.4 Macro-economic factor analysis:
3.2.5 Developing base number:
3.2.6 Data Triangulation:
3.2.7 Country level data:
4. South & Central America Hybrid Composites Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants:
4.2.2 Bargaining Power of Buyers:
4.2.3 Bargaining Power of Suppliers:
4.2.4 Competitive Rivalry:
4.2.5 Threat of Substitutes:
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. South & Central America Hybrid Composites Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Lightweight Materials in Aerospace & Defense Industry
5.1.2 Rising Use of Hybrid Composites in Wind Energy and Automotive Industries
5.2 Market Restraints
5.2.1 High Cost and Recyclability Issues of Hybrid Composites
5.3 Market Opportunities
5.3.1 Increasing Demand for Nanocomposites
5.4 Future Trends
5.4.1 Rise in Adoption of Biocomposites
5.5 Impact Analysis
6. Hybrid Composites – South & Central America Market Analysis
6.1 South & Central America Hybrid Composites Market Overview
6.2 South & Central America Hybrid Composites Market –Volume and Forecast to 2028 (Kilo Tons)
6.3 South & Central America Hybrid Composites Market –Revenue and Forecast to 2028 (US$ Million)
7. South & Central America Hybrid Composites Market Analysis – By Fiber Type
7.1 Overview
7.2 South & Central America Hybrid Composites Market, By Fiber Type (2022 and 2028)
7.3 Carbon/Aramid
7.3.1 Overview
7.3.2 Carbon/Aramid: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Carbon/Aramid: South & Central America Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.4 Carbon/Glass
7.4.1 Overview
7.4.2 Carbon/Glass: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Carbon/Glass: South & Central America Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.5 High-Modulus Polypropylene (HMPP)/Carbon
7.5.1 Overview
7.5.2 High-Modulus Polypropylene (HMPP)/Carbon: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 High-Modulus Polypropylene (HMPP)/Carbon: South & Central America Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.6 Ultra High Molecular Weight Polyethylene (UHMWPE)/ Carbon
7.6.1 Overview
7.6.2 Ultra High Molecular Weight Polyethylene (UHMWPE)/ Carbon: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 Ultra High Molecular Weight Polyethylene (UHMWPE)/ Carbon: South & Central America Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.7 Others
7.7.1 Overview
7.7.2 Others: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.7.3 Others: South & Central America Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
8. South & Central America Hybrid Composites Market Analysis – By Resin
8.1 Overview
8.2 South & Central America Hybrid Composites Market, By Resin(2022 and 2028)
8.3 Thermoset
8.3.1 Overview
8.3.2 Thermoset: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Thermoplastic
8.4.1 Overview
8.4.2 Thermoplastic: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Hybrid Composites Market Analysis – By Application
9.1 Overview
9.2 South & Central America Hybrid Composites Market, By Application (2022 and 2028)
9.3 Automotive
9.3.1 Overview
9.3.2 Automotive: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Aerospace
9.4.1 Overview
9.4.2 Aerospace: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Marine
9.5.1 Overview
9.5.2 Marine: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Wind Energy
9.6.1 Overview
9.6.2 Wind Energy: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Sporting Goods
9.7.1 Overview
9.7.2 Sporting Goods: South & Central America Hybrid Composites Market– Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: South & Central America Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Hybrid Composites Market – Country Analysis
10.1 Overview
10.1.1 South & Central America Hybrid Composites Market, by Key Country–Revenue (2022) (US$ Million)
10.1.2 South & Central America Hybrid Composites Market, by Key Country
10.1.2.1 Brazil: South & Central America Hybrid Composites Market –Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 Brazil: South & Central America Hybrid Composites Market –Volume and Forecast to 2028 (Kilo Tons)
10.1.2.2.1 Brazil: South & Central America Hybrid Composites Market, by Fiber Type
10.1.2.2.2 Brazil: South & Central America Hybrid Composites Market, by Fiber Type
10.1.2.2.3 Brazil: South & Central America Hybrid Composites Market, by Resin
10.1.2.2.4 Brazil: South & Central America Hybrid Composites Market, by Application
10.1.2.3 Argentina: South & Central America Hybrid Composites Market –Revenue and Forecast to 2028 (US$ Million)
10.1.2.4 Argentina: South & Central America Hybrid Composites Market –Volume and Forecast to 2028 (Kilo Tons)
10.1.2.4.1 Argentina: South & Central America Hybrid Composites Market, by Fiber Type
10.1.2.4.2 Argentina: South & Central America Hybrid Composites Market, by Fiber Type
10.1.2.4.3 Argentina: South & Central America Hybrid Composites Market, by Resin
10.1.2.4.4 Argentina: South & Central America Hybrid Composites Market, by Application
10.1.2.5 Rest of South & Central America: South & Central America Hybrid Composites Market –Revenue and Forecast to 2028 (US$ Million)
10.1.2.6 Rest of South & Central America: South & Central America Hybrid Composites Market –Volume and Forecast to 2028 (Kilo Tons)
10.1.2.6.1 Rest of South & Central America: South & Central America Hybrid Composites Market, by Fiber Type
10.1.2.6.2 Rest of South & Central America: South & Central America Hybrid Composites Market, by Fiber Type
10.1.2.6.3 Rest of South & Central America: South & Central America Hybrid Composites Market, by Resin
10.1.2.6.4 Rest of South & Central America: South & Central America Hybrid Composites Market, by Application
11. Hybrid Composite Market Industry Landscape
11.1 Overview
11.2 Product Launch
11.3 Merger and Acquisitions
11.4 Partnerships
11.5 Expansion
12. Company Profiles
12.1 Hexcel Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Lanxess AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 SGL Carbon SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Avient Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teijin Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Solvay SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Toray Industries Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Mitsubishi Chemical Holdings Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Vitamin K2 Market Segmentation
Table 2. North America Vitamin K2 Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Vitamin K2 Market, by Source – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Vitamin K2 Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 8. US Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 9. US Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 19. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) – Surgery
Table 20. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) – Source
Table 21. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) – Application
Table 22. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 23. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 24. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 25. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 26. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 27. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 28. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 29. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 30. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 31. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 32. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 35. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 36. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 37. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 38. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 39. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 40. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 41. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 42. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 43. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 44. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 45. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 46. Asia Pacific Vitamin K2 Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific Vitamin K2 Market, by Source – Revenue and Forecast to 2030 (US$ Million)
Table 49. Asia Pacific Vitamin K2 Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 50. China Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. China Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 52. China Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 53. China Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 54. Japan Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 57. Japan Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 58. India Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 59. India Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 60. India Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 61. India Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 62. Australia Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia Pacific Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 65. Australia Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 66. South Korea Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 69. South Korea Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Asia Pacific Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 73. Rest of Asia Pacific Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 74. Middle East and Africa Vitamin K2 Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East and Africa Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East and Africa Vitamin K2 Market, by Source – Revenue and Forecast to 2030 (US$ Million)
Table 77. Middle East and Africa Vitamin K2 Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 78. South Africa Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 79. South Africa Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 81. South Africa Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 82. Saudi Arabia Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 83. Saudi Arabia Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 85. Saudi Arabia Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 86. U.A.E Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 87. U.A.E Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 88. U.A.E Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 89. U.A.E Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Middle East and Africa Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East and Africa Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Middle East and Africa Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 94. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 95. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) – Surgery
Table 96. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) – Source
Table 97. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 98. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 99. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 100. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 101. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 102. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 103. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 104. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 105. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 106. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 107. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 108. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 109. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 110. Recent Organic Growth Strategies in Vitamin K2 Market
Table 111. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 112. Glossary of Terms, Vitamin K2 Market

LIST OF FIGURES

Figure 1. Vitamin K2 Market Segmentation, By Geography
Figure 2. North America – PEST Analysis
Figure 3. Vitamin K2 Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Vitamin K2 Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. MK-4: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. MK-7: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Combination Drugs: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 11. Capsules and Tablets: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Powder: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oil: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 15. Natural: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Synthetic: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 18. Pharmaceuticals: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Nutraceuticals and Food: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America: Vitamin K2 Market, by Key Country – Revenue (2022) (US$ Million)
Figure 22. North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: North America, by Country, 2022 & 2030 (%)
Figure 24. US: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Canada: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Mexico: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe Vitamin K2 Market, By Geography, 2022 ($Mn)
Figure 28. Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
Figure 30. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
Figure 31. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 32. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Asia Pacific: Vitamin K2 Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
Figure 40. China: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Japan: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. India: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Australia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. South Korea: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Rest of Asia Pacific: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Middle East and Africa: Vitamin K2 Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. Middle East and Africa Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
Figure 49. South Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Saudi Arabia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. U.A.E: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Rest of Middle East and Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Vitamin K2 Market, By Geography, 2022 ($Mn)
Figure 54. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Vitamin K2 Market, By Key Countries, 2022 and 2030 (%)
Figure 56. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Growth Strategies in Vitamin K2 Market

The List of Companies – Vitamin K2 Market
– Lonza Group Ag
– International Flavors & Fragrances Inc
– Balchem Corp
– BASF SE
– Lesaffre Et Cie Sa
– Seebio Biotech (Shanghai) Co Ltd
– Koninklijke DSM NV
– Novozymes As
– Glanbia Plc 
– Anderson Global Group LLC.

Reviews

There are no reviews yet.

Be the first to review “Vitamin K2 Market Size and Forecasts (2020 – 2030)”